文献速递水电解质与酸碱

噻嗪类相关低钠血症:临床表现与病理生理

Thiazide-Associated Hyponatremia: Clinical Manifestations and Pathophysiology.
PubMed 文献 · Am J Kidney Dis · 2019-10-09

本文综述噻嗪类相关低钠血症的临床表现与病理生理。易感个体使用噻嗪类可发生低钠血症,危险因素包括年龄、女性、可能低体重及遗传易感性;可早期或数月/数年后出现,多无症状或轻微,但急性者可致癫痫或昏迷。病理生理涉及水摄入过多、阳离子耗竭、钠渗透性失活及自由水排泄能力下降,治疗核心为停药、补阳离子和限水,严重者用3%盐水,避免过快纠正。

要点

  • 噻嗪类相关低钠血症的危险因素包括年龄、女性、可能低体重及遗传易感性。
  • 低钠血症可于用药早期或数月/数年后发生,急性者可能出现癫痫或昏迷。
  • 治疗核心为停用噻嗪类、补充阳离子和限水,严重者用3%盐水,避免过快纠正。

核心结论

  • 噻嗪类相关低钠血症可发生于易感个体,严重者致癫痫或昏迷,治疗以停药、补阳离子和限水为核心,严重者用3%盐水,避免过快纠正慢性低钠血症。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • 危险因素包括年龄、女性、可能低体重,近期发现遗传易感性。
  • 低钠血症常于噻嗪类治疗开始后早期发生,但许多病例在用药数月或数年后出现。
  • 许多病例无症状或症状轻微,但急性发作者可发生癫痫和/或昏迷。
  • 病理生理不完全清楚,涉及水摄入过多、钠钾耗竭、钠渗透性失活和自由水排泄能力下降等组合。

关键数值与推荐

  • 治疗核心为停用噻嗪类、补充阳离子和口服限水。
  • 严重症状者可考虑3%盐水。
  • 所有病例必须避免过快纠正慢性低钠血症。

临床怎么用

  • 对使用噻嗪类者应关注低钠血症风险,尤其高龄、女性、低体重及有遗传易感性者。
  • 发生低钠血症时首先停用噻嗪类、补充钠钾并限水,严重症状者用3%盐水。
  • 纠正慢性低钠血症时避免过快,以防渗透性脱髓鞘。

局限性

  • 病理生理不完全清楚,主要机制因人而异。
  • 检索范围未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hyponatremia can complicate thiazide use in a minority of susceptible individuals and can result in significant morbidity and even mortality. Risk factors for thiazide-associated hyponatremia include age, female sex, and possibly low body mass. A genetic susceptibility has recently been uncovered. Although frequently developing early after thiazide treatment initiation, many cases of hyponatremia present after months or years of use. Many cases are asymptomatic or have mild symptoms, but seizures and/or coma may develop, especially in those with acute onset. The pathophysiology is incompletely understood and includes some combination of excessive fluid intake, cation (sodium and potassium) depletion, osmotic inactivation of sodium, and reduced ability to excrete free water. Reduced distal delivery of filtrate, reduced solute load (urea), direct inhibition of the sodium-chloride cotransporter, and increased collecting duct permeability to water mediated by some combination of antidiuretic hormone, prostaglandins, and thiazides themselves may contribute to this diluting defect. The predominant pathophysiologic mechanism(s) varies from patient to patient. The cornerstone of therapy is cessation of thiazide use, cation repletion, and oral fluid restriction. If severely symptomatic, 3% saline solution may be indicated. Overly rapid correction of chronic hyponatremia must be avoided in all cases.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Filippone EJ, Ruzieh M, Foy A, et al. Thiazide-Associated Hyponatremia: Clinical Manifestations and Pathophysiology. Am J Kidney Dis. 2019. PMID: 31606239. doi:10.1053/j.ajkd.2019.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。